03:52 PM EDT, 07/08/2025 (MT Newswires) -- Health care stocks rose late Tuesday afternoon with the NYSE Health Care Index gaining 0.4% and the Health Care Select Sector SPDR Fund (XLV) advancing 0.5%.

The iShares Biotechnology ETF (IBB) climbed 1%.

In sector news, President Donald Trump reportedly threatened to impose a 200% tariff on pharmaceuticals imported into the US, according to media reports.

In corporate news, Progyny ( PGNY ) shares jumped 14%. The company expects Q2 results to be "slightly above" guidance from May.

Recursion Pharmaceuticals ( RXRX ) shares jumped 10% after the company gained full rights to REV102, a drug candidate for hypophosphatasia, after acquiring Rallybio's ( RLYB ) interest in the program. Rallybio ( RLYB ) surged 50%.

Pfizer ( PFE ) Chief Corporate Officer Sally Susman will leave the company at the end of the year. Pfizer ( PFE ) shares climbed 1.5%.

ProKidney ( PROK ) shares soared sixfold after the company said its investigational therapy rilparencel stabilized kidney function in a group of patients with chronic kidney disease and diabetes who received two injections about three months apart in a phase 2 trial, replicating the dosing regimen of its ongoing phase 3 study.